Tag Archive

The following is a list of all entries tagged with alzheimers disase:

Drug Regulators, EMEA, Re-Publish Guidance on Special Populations Geriatrics

This guideline is directed principally toward new Molecular Entities that are likely to have significant use in the elderly, either because the disease intended to be treated is characteristically a disease of aging ( e.g., Alzheimer’s disease) or because the population to be treated is known to include substantial numbers of geriatric patients (e.g., hypertension)